Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03768349 · ClinicalTrials.gov registry record · Early Phase 1

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

A Early Phase 1 study of Prostate Cancer, sponsored by Mayo Clinic.

Completed
Registry status
Early Phase 1
Development phase
250
Enrollment target
1
Study location

NCT03768349: Completed Early Phase 1 study of Prostate Cancer, sponsored by Mayo Clinic.

NCT03768349 is a Early Phase 1 study of Prostate Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03768349, a Early Phase 1 study of Prostate Cancer, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Early Phase 1
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Imaging and staging of prostate cancer is critical for surgical and treatment planning. In this protocol we will image patients with suspected metastatic prostate cancer using 11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or F-18 labeled PSMA 1007 in order to demonstrate their utility in detecting prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • DRUG Ga-68 PSMA11
  • DRUG F-18 PSMA 1007

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2019-01-03
Est. Completion 2021-07-21
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03768349

The ClinicalTrials.gov registry entry for NCT03768349 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (59% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Ga-68 PSMA11 is the first listed.

NCT03768349 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03768349 about?

NCT03768349 is a clinical study titled "PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer". Imaging and staging of prostate cancer is critical for surgical and treatment planning. In this protocol we will image patients with suspected metastatic prostate cancer using 11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or F-18 labeled PSMA 1007 in order t...

What is the current status of trial NCT03768349?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 250 participants. The study started on 2019-01-03. Estimated completion is 2021-07-21.

What conditions does trial NCT03768349 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03768349?

The interventions under investigation include: Ga-68 PSMA11 (DRUG), F-18 PSMA 1007 (DRUG).

Who is sponsoring clinical trial NCT03768349?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03768349 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.